Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Fig. 3

Associations between attainment of cSLEDAI-2K=0 ever during the 2-year follow-up period and levels of a, b anti-dsDNA and c, d anti-ribosomal P antigen in a, c serum obtained with conventional measurement and b, d in the corresponding solubilized IC. Horizontal lines indicate median values of each antibody, with the corresponding figures shown below each measure. ns not significant, Rib P ribosomal P antigen

Back to article page